Jack Horgan-Jones on Business
After all the hype, Irish biopharma’s golden child Malin Corp has turned out to be a bit of a brat
Exactly what is going on at Malin Corp? The publicly-quoted biopharma investor was launched amid great fanfare in 2015, when it raised €330 million in its initial public offering. Among the key investors at the time was the taxpayer, who put in around €50 million through the state’s Irish Strategic Investment Fund (Isif).
At the time, John Given, the then-chairman of the company, said that its goal was to create “value for shareholders ...